Sampathkumar Anandan

发表

Design and synthesis of thiazole-5-hydroxamic acids as novel histone deacetylase inhibitors.

T. Denny, R. Brokx, Sampathkumar Anandan, 2007, Bioorganic & medicinal chemistry letters.

N- and C-terminal modifications of negamycin.

Sampathkumar Anandan, D. Patel, C. Hackbarth, 2003, Bioorganic & medicinal chemistry letters.

Pharmacokinetics and Pharmacodynamics of AR9281, an Inhibitor of Soluble Epoxide Hydrolase, in Single‐ and Multiple‐Dose Studies in Healthy Human Subjects

Sampathkumar Anandan, D. Patel, D. Chen, 2012, Journal of clinical pharmacology.

1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia.

Paul D. Jones, B. Hammock, D. Macintyre, 2011, Bioorganic & medicinal chemistry letters.

Inhibition of soluble epoxide hydrolase attenuates endothelial dysfunction in animal models of diabetes, obesity and hypertension.

D. Macintyre, Sampathkumar Anandan, D. Chen, 2011, European journal of pharmacology.

Unsymmetrical non-adamantyl N,N'-diaryl urea and amide inhibitors of soluble expoxide hydrolase.

Sampathkumar Anandan, R. Gless, Zung N. Do, 2009, Bioorganic & medicinal chemistry letters.

Exploration of secondary and tertiary pharmacophores in unsymmetrical N,N'-diaryl urea inhibitors of soluble epoxide hydrolase.

Sampathkumar Anandan, R. Gless, 2010, Bioorganic & medicinal chemistry letters.

Non-urea functionality as the primary pharmacophore in soluble epoxide hydrolase inhibitors.

Sampathkumar Anandan, D. Patel, R. Gless, 2009, Bioorganic & medicinal chemistry letters.

Mercaptoamide-based non-hydroxamic acid type histone deacetylase inhibitors.

Sampathkumar Anandan, J. Ward, M. Bray, 2005, Bioorganic & medicinal chemistry letters.

Conformationally restricted analogs of deoxynegamycin.

Shihai Gu, Sampathkumar Anandan, D. Patel, 2004, Bioorganic & medicinal chemistry letters.

1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia.

S. Cases, Sampathkumar Anandan, J. Waszczuk, 2011, Bioorganic & medicinal chemistry letters.